Results 141 to 150 of about 197,641 (308)
Névtani Értesítő, 2014 This paper intends to explore for what purposes and by what means medieval personal names can be used in social historical research. Bynames derived from place names are examined in the present paper, as they prove to be essential sources in research ...
Gulyás, László Szabolcs
doaj
Névtani Értesítő, 2016 The comprehensive description of a country’s family name stock has been, and is being, carried out in several European countries, including Hungary. The paper, from among other possible lines of research, offers a typological-statistical survey of the ...
Farkas, Tamás
doaj
Névtani Értesítő, 2016 The 1055 Foundation Deed of Tihany Abbey, a precious linguistic record of the Hungarian language, includes several Hungarian place names and personal names inserted into the Latin text of the charter.
Szentgyörgyi, Rudolf
doaj
Cancer in Systemic Sclerosis: Clinical Associations and Prognostic Impact From the EUSTAR Registry
Arthritis &Rheumatology, EarlyView.Objective Cancer represents a major cause of death in systemic sclerosis (SSc). Established risk factors are limited to specific subsets, particularly early diffuse anti‐RNA polymerase III (POLR3)–positive disease, needing further exploration. Methods We performed a nested case‐control study within the European Scleroderma Trials and Research group ...
Antonio Tonutti +52 more
wiley +1 more source
Journal of the Association for Information Science and Technology, EarlyView.Abstract The issue of inequality caused by algorithms, termed ‘algorithmic inequality’, has recently attracted scholarly attention in many disciplines due to its profound implications for society. While the body of literature on algorithmic inequality has grown, there remains a lack of comprehensive understanding of its nature, drivers, and impact ...
Shiwei Jia, Jia Tina Du, Hui Yan
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source